Cancer Clinical Trial -IDEAYA Biosciences- 143026

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Drug

IDE196, Binimetinib, Crizotinib

Phase

Phase I

Condition

Breast, Cholangiocarcinoma, Squamous Cell Esophageal

Keywords

GNAQ/11 Mutations